Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)
- PMID: 26833145
- DOI: 10.1016/j.revmed.2015.12.015
Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)
Abstract
Purpose: Management of giant cell arteritis (GCA, Horton's disease) involves many uncertainties. This work was undertaken to establish French recommendations for GCA management.
Methods: Recommendations were developed by a multidisciplinary panel of 33 physicians, members of the French Study Group for Large Vessel Vasculitis (Groupe d'étude français des artérites des gros vaisseaux [GEFA]). The topics to be addressed, selected from proposals by group members, were assigned to subgroups to summarize the available literature and draft recommendations. Following an iterative consensus-seeking process that yielded consensus recommendations, the degree of agreement among panel members was evaluated with a 5-point Likert scale. A recommendation was approved when ≥ 80% of the voters agreed or strongly agreed.
Results: The 15 retained topics resulted in 31 consensus recommendations focusing on GCA nomenclature and classification, the role of temporal artery biopsy and medical imaging in the diagnosis, indications and search modalities for involvement of the aorta and its branches, the glucocorticoid regimen to prescribe, treatment of complicated GCA, indications for use of immunosuppressants or targeted biologic therapies, adjunctive treatment measures, and management of relapse and recurrence.
Conclusions: The recommendations, which will be updated regularly, are intended to guide and harmonize the standards of GCA management.
Keywords: Diagnosis; Giant cell arteritis; Recommendations; Treatment.
Copyright © 2016 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.
Similar articles
-
Giant cell arteritis: Commentary on recommendations of the French Study Group for Large Vessel Vasculitis (GEFA).Rev Med Interne. 2016 Mar;37(3):151-2. doi: 10.1016/j.revmed.2015.12.016. Epub 2016 Jan 15. Rev Med Interne. 2016. PMID: 26781693 No abstract available.
-
Use of immunosuppressants and biologics in giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA).Rev Med Interne. 2025 Jan;46(1):4-11. doi: 10.1016/j.revmed.2024.10.006. Epub 2024 Nov 4. Rev Med Interne. 2025. PMID: 39500637
-
[Clinical, laboratory, radiological features, and outcome in 26 patients with aortic involvement amongst a case series of 63 patients with giant cell arteritis].Rev Med Interne. 2014 Jan;35(1):4-15. doi: 10.1016/j.revmed.2013.06.007. Epub 2013 Jul 29. Rev Med Interne. 2014. PMID: 23906779 French.
-
[Giant-cell arteritis and Takayasu arteritis: epidemiological, diagnostic and treatment aspects].Presse Med. 2012 Oct;41(10):955-65. doi: 10.1016/j.lpm.2012.07.011. Epub 2012 Aug 31. Presse Med. 2012. PMID: 22940467 Review. French.
-
The diagnosis and classification of giant cell arteritis.J Autoimmun. 2014 Feb-Mar;48-49:73-5. doi: 10.1016/j.jaut.2014.01.017. Epub 2014 Jan 21. J Autoimmun. 2014. PMID: 24461386 Review.
Cited by
-
Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.Nat Rev Rheumatol. 2020 Sep;16(9):481-495. doi: 10.1038/s41584-020-0458-5. Epub 2020 Aug 5. Nat Rev Rheumatol. 2020. PMID: 32759996 Review.
-
[Management of polymyalgia rheumatica and large vessel vasculitis].Internist (Berl). 2016 Nov;57(11):1069-1078. doi: 10.1007/s00108-016-0131-x. Internist (Berl). 2016. PMID: 27631531 Review. German.
-
Temporal Artery Vascular Diseases.J Clin Med. 2022 Jan 5;11(1):275. doi: 10.3390/jcm11010275. J Clin Med. 2022. PMID: 35012016 Free PMC article. Review.
-
Presentation and Real-World Management of Giant Cell Arteritis (Artemis Study).Front Med (Lausanne). 2021 Nov 11;8:732934. doi: 10.3389/fmed.2021.732934. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34859001 Free PMC article.
-
Interdisciplinary approach in the management of visual loss in giant cell arteritis.Saudi J Ophthalmol. 2024 Nov 18;39(1):14-19. doi: 10.4103/sjopt.sjopt_236_24. eCollection 2025 Jan-Mar. Saudi J Ophthalmol. 2024. PMID: 40182961 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical